BACKGROUND: For several decades, diagnoses of genital warts at genitourinary medicine (GUM) clinics in England had been increasing. In 2008, a national human papillomavirus (HPV) vaccination programme was introduced using the bivalent vaccine (types 16 and 18 only). A decrease in genital warts was not anticipated. However, rates of genital warts in GUM clinics have declined significantly since the introduction of the vaccine. METHODS: Using data from GUM clinics across England, we analysed rates of genital warts by age, gender, sexual orientation and estimated vaccine coverage. RESULTS: The reduction in rates of genital warts diagnoses at GUM clinics between 2009 and 2014 was 30.6% among young women aged 15-19 years and 25.4% among same age heterosexual young men. Overall there was an association showing higher warts reduction with increasing vaccination coverage with the largest declines in warts diagnoses observed in young women aged 15 years (50.9%) with the highest vaccination coverage. No such declines were observed in men who have sex with men (MSM) of the same age. CONCLUSION: The results of these ecological analyses are strongly in keeping with the bivalent HPV vaccine providing modest protection against genital warts. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
BACKGROUND: For several decades, diagnoses of genital warts at genitourinary medicine (GUM) clinics in England had been increasing. In 2008, a national human papillomavirus (HPV) vaccination programme was introduced using the bivalent vaccine (types 16 and 18 only). A decrease in genital warts was not anticipated. However, rates of genital warts in GUM clinics have declined significantly since the introduction of the vaccine. METHODS: Using data from GUM clinics across England, we analysed rates of genital warts by age, gender, sexual orientation and estimated vaccine coverage. RESULTS: The reduction in rates of genital warts diagnoses at GUM clinics between 2009 and 2014 was 30.6% among young women aged 15-19 years and 25.4% among same age heterosexual young men. Overall there was an association showing higher warts reduction with increasing vaccination coverage with the largest declines in warts diagnoses observed in young women aged 15 years (50.9%) with the highest vaccination coverage. No such declines were observed in men who have sex with men (MSM) of the same age. CONCLUSION: The results of these ecological analyses are strongly in keeping with the bivalent HPV vaccine providing modest protection against genital warts. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Authors: Oliver Damm; Johannes Horn; Rafael T Mikolajczyk; Mirjam E E Kretzschmar; Andreas M Kaufmann; Yvonne Deleré; Bernhard Ultsch; Ole Wichmann; Alexander Krämer; Wolfgang Greiner Journal: Cost Eff Resour Alloc Date: 2017-09-04
Authors: Maria Zurek Munk-Madsen; Lars Toft; Tina Kube; Rolf Richter; Lars Ostergaard; Ole S Søgaard; Martin Tolstrup; Andreas M Kaufmann Journal: Hum Vaccin Immunother Date: 2017-12-20 Impact factor: 3.452
Authors: Pascal van der Weele; Martijn Breeuwsma; Robine Donken; Elske van Logchem; Naomi van Marm-Wattimena; Hester de Melker; Chris J L M Meijer; Audrey J King Journal: PLoS One Date: 2019-03-04 Impact factor: 3.240
Authors: Pam Sonnenberg; Clare Tanton; David Mesher; Eleanor King; Simon Beddows; Nigel Field; Catherine H Mercer; Kate Soldan; Anne M Johnson Journal: Sex Transm Infect Date: 2019-02-05 Impact factor: 3.519
Authors: Georges Van Kriekinge; Woo-Yun Sohn; Syed Mohamed Aljunid; Ruey Soon; Chee-Meng Yong; Jing Chen; I-Heng Lee Journal: Asian Pac J Cancer Prev Date: 2018-04-25